{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:22:58Z","timestamp":1763036578980},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T00:00:00Z","timestamp":1297900800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1001085","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T19:41:00Z","timestamp":1297971660000},"page":"e1001085","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Dynamical Systems Model for Combinatorial Cancer Therapy Enhances Oncolytic Adenovirus Efficacy by MEK-Inhibition"],"prefix":"10.1371","volume":"7","author":[{"given":"Neda","family":"Bagheri","sequence":"first","affiliation":[]},{"given":"Marisa","family":"Shiina","sequence":"additional","affiliation":[]},{"given":"Douglas A.","family":"Lauffenburger","sequence":"additional","affiliation":[]},{"given":"W. Michael","family":"Korn","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"ref1","first-page":"217","article-title":"Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.","volume":"1785","author":"ZS Guo","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1016-8478(23)17606-0","article-title":"The current status of adenovirus-based cancer gene therapy.","volume":"25","author":"T Shirakawa","year":"2008","journal-title":"Mol Cells"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/cgt.2009.3","article-title":"Armed replicating adenoviruses for cancer virotherapy.","volume":"16","author":"JJ Cody","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712590903559822","article-title":"Oncolytic (replication-competent) adenoviruses as anticancer agents.","volume":"10","author":"K Toth","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","article-title":"Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection.","volume":"156","author":"DD Barker","year":"1987","journal-title":"Virology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ccr.2004.11.012","article-title":"Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.","volume":"6","author":"CC O'Shea","year":"2004","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/80466","article-title":"Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).","volume":"6","author":"SJ Ries","year":"2000","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.","volume":"10","author":"EA Chiocca","year":"2004","journal-title":"Mol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.gt.3302436","article-title":"Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.","volume":"12","author":"E Galanis","year":"2005","journal-title":"Gene Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.cgt.7700431","article-title":"Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.","volume":"9","author":"N Habib","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"ref11","first-page":"693","article-title":"Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.","volume":"9","author":"D Makower","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref12","first-page":"798","article-title":"A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.","volume":"6","author":"I Ganly","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.gt.3301512","article-title":"Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.","volume":"8","author":"T Reid","year":"2001","journal-title":"Gene Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.20.6.1562","article-title":"Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent\/refractory epithelial ovarian cancer.","volume":"20","author":"PA Vasey","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/0008-5472.CAN-05-2328","article-title":"Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition.","volume":"66","author":"MD Lacher","year":"2006","journal-title":"Cancer Res"},{"key":"ref16","first-page":"2088","article-title":"Inhibition of the Raf\/MEK\/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.","volume":"63","author":"M Anders","year":"2003","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.4161\/cc.5.19.3263","article-title":"E1B55K-deleted adenovirus (ONYX-015) overrides G1\/S and G2\/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells.","volume":"5","author":"G Cherubini","year":"2006","journal-title":"Cell Cycle"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1128\/JVI.73.9.7474-7488.1999","article-title":"Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication.","volume":"73","author":"FD Goodrum","year":"1999","journal-title":"J Virol"},{"key":"ref19","first-page":"xv, 589","article-title":"Viral vectors for gene therapy : methods and protocols","author":"CA Machida","year":"2003"},{"key":"ref20","first-page":"120","article-title":"A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.","volume":"7","author":"K Suzuki","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11538-009-9456-0","article-title":"Optimization of virotherapy for cancer.","volume":"72","author":"M Biesecker","year":"2010","journal-title":"Bull Math Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jtbi.2010.01.009","article-title":"ODE models for oncolytic virus dynamics.","volume":"263","author":"NL Komarova","year":"2010","journal-title":"J Theor Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1078-0432.CCR-08-2082","article-title":"Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.","volume":"15","author":"W Mok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1158\/0008-5472.CAN-08-2173","article-title":"A multiscale mathematical model for oncolytic virotherapy.","volume":"69","author":"LR Paiva","year":"2009","journal-title":"Cancer Res"},{"key":"ref25","first-page":"1317","article-title":"Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery.","volume":"63","author":"LM Wein","year":"2003","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s11425-008-0070-7","article-title":"A mathematical model of combined therapies against cancer using viruses and inhibitors.","volume":"51","author":"Y Tao","year":"2008","journal-title":"Science in China Series A: Mathematics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2006.09.029","article-title":"Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus.","volume":"245","author":"R Zurakowski","year":"2007","journal-title":"J Theor Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/10533","article-title":"Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo.","volume":"5","author":"JS Sebolt-Leopold","year":"1999","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1128\/JVI.77.15.8593-8595.2003","article-title":"E4orf3 is necessary for enhanced S-phase replication of cell cycle-restricted subgroup C adenoviruses.","volume":"77","author":"RN Shepard","year":"2003","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/JVI.01708-07","article-title":"Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.","volume":"82","author":"X Zheng","year":"2008","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/cgt.2009.70","article-title":"Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor.","volume":"17","author":"JC Tseng","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"ref32","first-page":"1","article-title":"Selectivity of Oncolytic Viral Replication Prevents Antiviral Immune Response and Toxicity, but Does Not Improve Antitumoral Immunity.","author":"E Gurlevik","year":"2010","journal-title":"Mol Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.","volume":"19","author":"J Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.","volume":"275","author":"JM Bergelson","year":"1997","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cyto.a.20623","article-title":"MIFlowCyt: the minimum information about a Flow Cytometry Experiment.","volume":"73","author":"JA Lee","year":"2008","journal-title":"Cytometry A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/cgt.2009.29","article-title":"RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.","volume":"16","author":"M Shiina","year":"2009","journal-title":"Cancer Gene Ther"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1001085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:11:46Z","timestamp":1712218306000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1001085"}},"subtitle":[],"editor":[{"given":"Christopher V.","family":"Rao","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,2,17]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1001085","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,17]]}}}